Hypoxic-Ischemic Encephalopathy
89
13
19
41
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Published Results
13 trials with published results (15%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
3.4%
3 terminated out of 89 trials
93.2%
+6.6% vs benchmark
7%
6 trials in Phase 3/4
32%
13 of 41 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 41 completed trials
Clinical Trials (89)
Prognostic Factors to Regain Consciousness
Spinal Stimulation and Mobility Devices
Comparative Outcomes Related to Delivery-room Cord Milking In Low-resourced Kountries
School-aged Outcomes Post Hypoxic Ischaemic Encephalopathy
Renal and Cerebral NIRS and Early Acute Kidney Injury in Cooled Neonates With Birth Asphyxia
Dose Optimization of Caffeine for HIE
EEG-Based Decision-Support Algorithm for Hypoxic-Ischemic Encephalopathy in Term Newborns
Effects of a Physical Therapy Intervention on Motor Delay in Infants Admitted to a Neonatal Intensive Care Unit
Evaluating a Wireless NIRS Device in the Neonatal Intensive Care Unit
Neonatal Neurological Observation With Video AI
Comparative Outcomes Related to Delivery-room Cord Milking In Low-resourced Kountries Developmental Follow Up
Therapeutic Intervention Supporting Development From NICU to 6 Months for Infants Post Hypoxic-Ischemic Encephalopathy
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
A Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures
Identification of a Pool of miRNA to Improve Early Management of Perinatal Asphyxia and Hypoxic Ischemic Encephalopathy
Healthy Little Eyes
Predicting Mortality in Patients With Return of Spontaneous Circulation After Cardiac Arrest
Individual Cerebral Hemodynamic Oxygenation Relationships (ICHOR 1)
Hydrocortisone Therapy Optimization During Hypothermia Treatment in Asphyxiated Neonates
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of RLS-0071 in Newborns With Moderate or Severe Hypoxic-Ischemic Encephalopathy Undergoing Therapeutic Hypothermia